EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling

Jingduo Deng, Wenke Yu, Weiming Yan, Xiaona Fang iD, Yu Zhang, Yishan Peng iD, Yu Nie iD, Xinyi Zhou, Bin Yang, Zeheng Feng, Siqi Chen, Qishan Liu und 10 weitere

Advanced Science · 16.11.2026

DOI: 10.1002/advs.78700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.11.2026. Verfasst von Jingduo Deng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery II, Guangdong Engineering Technology Research Center of Artificial Organ and Tissue Engineering, Guangzhou Clinic…. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of President of Zhujiang Hospital, Guangdong Yiyang Healthcare Charity Foundation, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is characterized by high recurrence, metastasis, and therapeutic resistance, with cancer stem cells (CSCs) contributing substantially to these malignant features. In this study, we identify WD repeat‐containing protein 76 (WDR76) as a key oncofetal regulator of liver cancer stemness. Transcriptomic profiling of an in vitro hepatocyte differentiation model revealed that WDR76 is highly expressed in embryonic stem cells, suppressed during hepatocyte maturation, and aberrantly reactivated in HCC. Clinically, WDR76 upregulation correlated with poor differentiation, advanced stage, and reduced patient survival. Functional assays demonstrated that WDR76 enhances CSC‐like properties, including self‐renewal, invasion, and lenvatinib resistance, while suppressing hepatocytic differentiation. Mechanistically, WDR76 recruits the deubiquitinase USP14 to stabilize the chromatin‐binding protein CBX5 by preventing its ubiquitination and degradation. Stabilized CBX5 undergoes liquid‐liquid phase separation, promoting heterochromatin condensation and chromatin reprogramming, thereby activating stemness‐associated genes. Loss‐and gain‐of‐function studies confirmed CBX5 as an essential downstream effector of WDR76 in driving HCC stemness and tumor progression. Finally, siRNA‐loaded nanoparticles targeting WDR76 synergized with lenvatinib to suppress tumor growth in preclinical models. Together, these findings establish a WDR76‐USP14‐CBX5 axis as a pivotal pathway sustaining CSC phenotypes and nominate WDR76 as a promising diagnostic and therapeutic target in HCC.

Schlagwörter

Stichwörter der Autor:innen

biologycancer researchcancer stem cellcellular differentiationchromatinchromatin remodelingdownregulation and upregulationmetastasisstem celltumor progression

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery II, Guangdong Engineering Technology Research Center of Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute…
  • State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou, People's Republic of China.
  • Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center For Cancer Medicine, Sun Yat-sen University Ca…
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.

ORCID-Profile: Xiaona Fang, Yishan Peng, Yu Nie, Xin-Yuan Guan, Mingxin Pan, Yi Gao, Qian Yan, Yuan Cheng

Förderung

  • Foundation of President of Zhujiang Hospital
  • Guangdong Yiyang Healthcare Charity Foundation
  • Guangzhou Municipal Science and Technology Project
  • Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • Natural Science Foundation of Guangdong Province: 2023A1515010563, 2025A1515012619
  • National Natural Science Foundation of China: 82473016, 82273345, 82403654

Zitieren

APA

Deng, J., Yu, W., Yan, W., Fang, X., Zhang, Y., Peng, Y., Nie, Y., Zhou, X., Yang, B., Feng, Z., Chen, S., Liu, Q., Xie, Y., Du, Y., Song, J., Yuan, Y., Xie, J., Guan, X. Y., Pan, M., …, & Cheng, Y. (2026). WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling. Advanced Science. https://doi.org/10.1002/advs.78700

Vancouver

Deng J, Yu W, Yan W, Fang X, Zhang Y, Peng Y, et al. WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling. Advanced Science. 2026. doi:10.1002/advs.78700

BibTeX
@article{Deng2026,
  author = {Deng, Jingduo and Yu, Wenke and Yan, Weiming and Fang, Xiaona and Zhang, Yu and Peng, Yishan and Nie, Yu and Zhou, Xinyi and Yang, Bin and Feng, Zeheng and Chen, Siqi and Liu, Qishan and Xie, Yongxin and Du, Yaqing and Song, Jianning and Yuan, Yuhai and Xie, Juntao and Guan, Xin-Yuan and Pan, Mingxin and Gao, Yi and Yan, Qian and Cheng, Yuan},
  title = {WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78700}
}
Kostenlos starten →